🇺🇸 FDA
Patent

US 8481311

Progenitor cells from wharton's jelly of human umbilical cord

granted A61KA61K35/51

Quick answer

US patent 8481311 (Progenitor cells from wharton's jelly of human umbilical cord) held by Tissue Regeneration Therapeutics Inc. expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Tissue Regeneration Therapeutics Inc.
Grant date
Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K35/51